Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferritin heavy chain 1 pseudogene 23 (FTH1P23) is a **processed pseudogene**, meaning it is a non-functional copy of the ferritin heavy chain 1 (FTH1) gene[1][9]. Although originally annotated as a pseudogene, studies have shown that similar pseudogenes such as FTH1P3 are **transcriptionally active** and may be **widely expressed in human tissues**, functioning at the RNA level rather than encoding a protein[7][9]. Like other ferritin heavy chain pseudogenes, FTH1P23 may possess **regulatory roles**, potentially affecting the expression and translation of the functional FTH1 gene via molecular mechanisms involving microRNAs (miRNAs) or RNA-binding proteins, especially given the presence of conserved iron-responsive element (IRE) sequences in the untranslated regions of these transcripts[7][9]. However, there is no evidence that FTH1P23 directly encodes a functional protein or serves as a typical drug target, receptor, enzyme, or transporter in therapeutic development[1][9]. Its biological roles are mainly speculative and relate to gene regulation within the ferritin gene family network rather than direct physiological or pharmacological functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferritin heavy chain 1 pseudogene 23 (FTH1P23).